David W Evans1, Laina G Lusk1,2, Mylissa M Slane2, Andrew M Michael2, Scott M Myers2, Mirko Uljarević3, Oliver Mason4, Gordon Claridge5, Thomas Frazier6. 1. Department of Psychology, Program in Neuroscience, Bucknell University, Lewisburg, PA, USA. 2. Geisinger Health System, Danville, PA, USA. 3. Olga Tennison Autism Research Centre, School of Psychology and Public Health, La Trobe University, Melbourne, Vic, Australia. 4. School of Psychology, University of Surrey Stag Hill, Guilford, Surrey, UK. 5. Department of Experimental Psychology, Oxford University, Oxford, UK. 6. Cleveland Clinic Children's Hospital, Center for Pediatric Behavioral Health, Cleveland, OH, USA.
Abstract
BACKGROUND: Healthy functioning relies on a variety of perceptual, cognitive, emotional, and behavioral abilities that are distributed throughout the normal population. Variation in these traits define the wide range of neurodevelopmental (NDD) and neuropsychiatric (NPD) disorders. Here, we introduce a new measure for assessing these traits in typically developing children and children at risk for NDD and NPD from age 2 to 18 years. METHOD: The Childhood Oxford-Liverpool Inventory of Feelings and Experiences (CO-LIFE) was created as a dimensional, parent-report measure of schizotypal and psychotic traits in the general population. Parents of 2,786 children also self-reported on an adapted version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE-US). RESULTS: The CO-LIFE resulted in continuous distributions for the total score and for each of three factor analytically-derived subscales. Item response theory (IRT) analyses indicated strong reliability across the score range for the O-LIFE-US and the CO-LIFE. Internal consistency and test-retest reliability were high across all scales. Parent-child intraclass correlations were consistent with high heritability. The scales discriminated participants who reported a lifetime psychiatric diagnosis from those who reported no diagnosis. The O-LIFE-US and CO-LIFE scores correlated positively with the Social Responsiveness Scale 2 (SRS-2) indicating good convergent validity. CONCLUSIONS: Like the original O-LIFE, the O-LIFE-US and the CO-LIFE are valid and reliable tools that reflect the spectrum of psychiatric and schizotypal traits in the general population. Such scales are necessary for conducting family studies that aim to examine a range of psychological and behavioral traits in both children and adults and are well-suited for the Research Domain Criteria (RDoC) initiative of the NIMH.
BACKGROUND: Healthy functioning relies on a variety of perceptual, cognitive, emotional, and behavioral abilities that are distributed throughout the normal population. Variation in these traits define the wide range of neurodevelopmental (NDD) and neuropsychiatric (NPD) disorders. Here, we introduce a new measure for assessing these traits in typically developing children and children at risk for NDD and NPD from age 2 to 18 years. METHOD: The Childhood Oxford-Liverpool Inventory of Feelings and Experiences (CO-LIFE) was created as a dimensional, parent-report measure of schizotypal and psychotic traits in the general population. Parents of 2,786 children also self-reported on an adapted version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE-US). RESULTS: The CO-LIFE resulted in continuous distributions for the total score and for each of three factor analytically-derived subscales. Item response theory (IRT) analyses indicated strong reliability across the score range for the O-LIFE-US and the CO-LIFE. Internal consistency and test-retest reliability were high across all scales. Parent-child intraclass correlations were consistent with high heritability. The scales discriminated participants who reported a lifetime psychiatric diagnosis from those who reported no diagnosis. The O-LIFE-US and CO-LIFE scores correlated positively with the Social Responsiveness Scale 2 (SRS-2) indicating good convergent validity. CONCLUSIONS: Like the original O-LIFE, the O-LIFE-US and the CO-LIFE are valid and reliable tools that reflect the spectrum of psychiatric and schizotypal traits in the general population. Such scales are necessary for conducting family studies that aim to examine a range of psychological and behavioral traits in both children and adults and are well-suited for the Research Domain Criteria (RDoC) initiative of the NIMH.
Authors: Pamela DeRosse; George C Nitzburg; Toshikazu Ikuta; Bart D Peters; Anil K Malhotra; Philip R Szeszko Journal: Schizophr Bull Date: 2014-11-11 Impact factor: 9.306
Authors: Thomas Insel; Bruce Cuthbert; Marjorie Garvey; Robert Heinssen; Daniel S Pine; Kevin Quinn; Charles Sanislow; Philip Wang Journal: Am J Psychiatry Date: 2010-07 Impact factor: 18.112
Authors: G Katherine S Lymer; Dominic E Job; T William; J Moorhead; Andrew M McIntosh; David G C Owens; Eve C Johnstone; Stephen M Lawrie Journal: Neuroimage Date: 2006-08-22 Impact factor: 6.556
Authors: Matcheri S Keshavan; Vaibhav A Diwadkar; Debra M Montrose; Rajaprabhakaran Rajarethinam; John A Sweeney Journal: Schizophr Res Date: 2005-11-01 Impact factor: 4.939
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Paul Lichtenstein; Benjamin H Yip; Camilla Björk; Yudi Pawitan; Tyrone D Cannon; Patrick F Sullivan; Christina M Hultman Journal: Lancet Date: 2009-01-17 Impact factor: 79.321
Authors: Andres Moreno-De-Luca; Scott M Myers; Thomas D Challman; Daniel Moreno-De-Luca; David W Evans; David H Ledbetter Journal: Lancet Neurol Date: 2013-03-18 Impact factor: 44.182
Authors: Helena M S Zavos; Daniel Freeman; Claire M A Haworth; Philip McGuire; Robert Plomin; Alastair G Cardno; Angelica Ronald Journal: JAMA Psychiatry Date: 2014-09 Impact factor: 21.596
Authors: Darren Hedley; Mirko Uljarević; Ru Ying Cai; Simon M Bury; Mark A Stokes; David W Evans Journal: PLoS One Date: 2021-01-22 Impact factor: 3.240